Popular
The Treatment Planning Process for Atopic Dermatitis
Dermatology Hub: Neuroimmune NetworkThe Treatment Planning Process for Atopic Dermatitis
Brad Glick, DO, MPH
Tapinarof’s Place in Inflammatory Disease Treatment
Practical DermatologyTapinarof’s Place in Inflammatory Disease Treatment
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
Mechanism of Action for Aryl Hydrocarbon Receptor Agonists
Practical DermatologyMechanism of Action for Aryl Hydrocarbon Receptor Agonists
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
Antihistamine Selection and Measuring Disease Control in Chronic Spontaneous Urticaria
Practical DermatologyAntihistamine Selection and Measuring Disease Control in Chronic Spontaneous Urticaria
Michelle B. Tarbox, MD
Programs
Potential Impact of Aryl Hydrocarbon Activation on Pigment
Practical DermatologyPotential Impact of Aryl Hydrocarbon Activation on Pigment
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
Mechanism of Action for Aryl Hydrocarbon Receptor Agonists
Practical DermatologyMechanism of Action for Aryl Hydrocarbon Receptor Agonists
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
ADORING Trials Show Broad Efficacy, Early Itch Relief
Practical DermatologyADORING Trials Show Broad Efficacy, Early Itch Relief
Jonathan Silverberg, MD, PhD, MPH
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Why Lower-Frequency Dosing Can Be Helpful in Atopic Dermatitis
Practical DermatologyWhy Lower-Frequency Dosing Can Be Helpful in Atopic Dermatitis
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Using Topical Therapies for Pediatric Atopic Dermatitis
Practical DermatologyUsing Topical Therapies for Pediatric Atopic Dermatitis
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Clinical Practice
Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
CME/CEContinuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
Stephen Brunton, MD, FAAFP, CDCES
James R. Gavin III, MD, PhD
Davida F. Kruger, MSN, APN-BC, BC-ADM
Eden Miller, DO, D-ACD, D-ABOM
Sticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
CME/CESticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
Dakota Price, MD
Emma Atkinson, PharmD
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
CME/CETranslating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
Christian Schulze, MD, PhD
Ahmad Masri, MD, MS
Michelle Michels, MD
Individualizing Management Strategies for PSVT: Incorporating Patient Preference
MinuteCE®Individualizing Management Strategies for PSVT: Incorporating Patient Preference
Jennifer Carlquist, PA-C
Sean Pokorney, MD, MBA
Brian P. Rose, PA-C, MPH
Beyond Steroids in Warm AIHA: A Practical Framework for Diagnosis, Relapse Management, and Emerging Therapies
CME/CEBeyond Steroids in Warm AIHA: A Practical Framework for Diagnosis, Relapse Management, and Emerging Therapies
Caroline Piatek, MD
Anthony L. Nguyen, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
MinuteCE®Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Doctors Lounge
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Heart MattersAdvancing ATTR-CM Identification: Early Findings from TRACE-AI
Bruno Batinica, MD
Collaboration in Medical Affairs: Increasing Value and Impact
MAPSChatsCollaboration in Medical Affairs: Increasing Value and Impact
Matt Birnholz, MD
Renu Juneja, PhD
Brian P. McDonough, MD, FAAFP
Michael Moor, MD, PhD
The Science of Exceptions: Setting the Safety Bar for Clinical AI
The ConvergenceThe Science of Exceptions: Setting the Safety Bar for Clinical AI
Brian P. McDonough, MD, FAAFP
Suvrankar Datta, MD
Turning Insight into Action: The Expanding Role of Medical Affairs
MAPSChatsTurning Insight into Action: The Expanding Role of Medical Affairs
Matt Birnholz, MD
Michael DeLuca, PharmD, MBA, MSRA
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
Jean-Claude Saghbini
CME
Moving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
CME/CEMoving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
Nosheen Reza, MD
Anjali Tiku Owens, MD
Pieter Martens, MD, MSc, PhD
Navigating the Limitations of Current BD Therapies
MinuteCE®Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
The Unmet Need in ASCVD: Why Targets Are Still Not Enough
MinuteCE®The Unmet Need in ASCVD: Why Targets Are Still Not Enough
Erin Michos
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
MinuteCE®Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Secondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
CME/CE Broadcast ReplaySecondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
Deborah Kerrigan, MD
Clay Johnston, MD
- MinuteCE®
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Industry Feature
Courtney Crawford, MD, FACS
Raj Maturi, MD
Advancing Care in Pediatric Atopic Dermatitis
DermConsultAdvancing Care in Pediatric Atopic Dermatitis
Jennifer Caudle, DO, FACOFP
Nicole Chase, MD
Fred Ghali, MD, FAAD
Treatment Considerations in Ulcerative Colitis: Shared Decision-Making
Medical Industry FeatureTreatment Considerations in Ulcerative Colitis: Shared Decision-Making
David T. Rubin, MD
Josh Steinberg, MD
Taking Action in Friedreich Ataxia From Diagnosis to Treatment
Medical Industry FeatureTaking Action in Friedreich Ataxia From Diagnosis to Treatment
Jennifer Caudle, DO, FACOFP
David Lynch, MD
Laura Bleekrode, MD
Time Matters in Severe Alopecia Areata: A Patient’s Journey to Fast Hair Regrowth
Medical Industry FeatureTime Matters in Severe Alopecia Areata: A Patient’s Journey to Fast Hair Regrowth
Meena Singh, MD, FAAD
Brandi Jones
Applying a “Do No Harm” Mindset to Moderate-to-Severe Plaque Psoriasis Treatment Selection
Medical Industry FeatureApplying a “Do No Harm” Mindset to Moderate-to-Severe Plaque Psoriasis Treatment Selection
Charles Turck, PharmD, BCPS, BCCCP
Sam Awan, MD
Tina Bhutani, MD, MAS